IL121217A - Pharmaceutical compositions containing pentosan polysulfate for treating chronic progressive vascular diseases - Google Patents
Pharmaceutical compositions containing pentosan polysulfate for treating chronic progressive vascular diseasesInfo
- Publication number
- IL121217A IL121217A IL12121796A IL12121796A IL121217A IL 121217 A IL121217 A IL 121217A IL 12121796 A IL12121796 A IL 12121796A IL 12121796 A IL12121796 A IL 12121796A IL 121217 A IL121217 A IL 121217A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- vascular diseases
- treating chronic
- pentosan polysulfate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/478,347 US5643892A (en) | 1995-06-07 | 1995-06-07 | Method of treating chronic progressive vascular diseases |
| PCT/US1996/008367 WO1996040158A1 (en) | 1995-06-07 | 1996-06-03 | Method of treating chronic progressive vascular diseases |
| BR9704114-9A BR9704114A (pt) | 1995-06-07 | 1997-07-28 | Processo de tratamento de doenças vasculares progressivas crÈnicas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL121217A0 IL121217A0 (en) | 1999-10-28 |
| IL121217A true IL121217A (en) | 2000-09-28 |
Family
ID=25664870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12121796A IL121217A (en) | 1995-06-07 | 1996-06-03 | Pharmaceutical compositions containing pentosan polysulfate for treating chronic progressive vascular diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5643892A (xx) |
| EP (1) | EP0809505B1 (xx) |
| AU (1) | AU699012B2 (xx) |
| BR (1) | BR9704114A (xx) |
| CA (1) | CA2210351C (xx) |
| DE (1) | DE809505T1 (xx) |
| ES (1) | ES2115571T3 (xx) |
| HU (1) | HUP9802431A3 (xx) |
| IL (1) | IL121217A (xx) |
| NO (1) | NO313686B1 (xx) |
| NZ (1) | NZ309991A (xx) |
| TW (1) | TW434018B (xx) |
| WO (1) | WO1996040158A1 (xx) |
| ZA (1) | ZA964247B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010005720A1 (en) * | 1995-06-07 | 2001-06-28 | U.S.A. As Represented By The Secretary Department Of Health And Human Services | Method of treating chronic progressive vascular scarring diseases |
| US6255295B1 (en) | 1996-12-23 | 2001-07-03 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue |
| UA65587C2 (en) | 1997-10-09 | 2004-04-15 | Baker Norton Pharma | Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus |
| DE19747195A1 (de) * | 1997-10-24 | 1999-04-29 | Knoll Ag | Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten |
| WO2001052867A1 (en) * | 2000-01-19 | 2001-07-26 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of pentosan polysulfate to treat certain conditions of the prostate |
| WO2007014155A2 (en) * | 2005-07-22 | 2007-02-01 | Trf Pharma, Inc. | Method for treating sickle cell disease and sickle cell disease sequelae |
| DK2010220T3 (da) * | 2006-04-03 | 2022-05-23 | Ceva Animal Health Pty Ltd | Stabiliserede pentosanpolysulfat-(pps)-formuleringer |
| EP2407174B1 (en) | 2009-03-11 | 2014-05-07 | Jellice Co., Ltd. | Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses |
| WO2011088418A2 (en) * | 2010-01-15 | 2011-07-21 | Mount Sinai School Of Medicine | Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate |
| JP6175431B2 (ja) | 2011-06-20 | 2017-08-02 | アイカーン スクール オブ メディシン アット マウント サイナイ | ムコ多糖症およびその他のリソソーム障害に対する抗ｔｎｆ療法 |
| US20130273096A1 (en) * | 2011-10-05 | 2013-10-17 | Bruce A. Daniels | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients |
| AU2018437600B2 (en) | 2018-08-20 | 2022-11-17 | Reqmed Company, Ltd. | Novel pentosan polysulfate sodium preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820693A (en) * | 1986-05-22 | 1989-04-11 | Angiogenics, Ltd. | Method and composition for arresting angiogenesis and capillary, cell or membrane leakage |
| US4966890A (en) * | 1986-04-04 | 1990-10-30 | Angiogenics, Ltd. | Method and composition for arresting angiogenesis and capillary, cell or membrane leakage |
| DE3725554A1 (de) * | 1987-08-01 | 1989-02-09 | Hoechst Ag | Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung |
| US5032679A (en) * | 1988-12-15 | 1991-07-16 | Glycomed, Inc. | Heparin fragments as inhibitors of smooth muscle cell proliferation |
| EP0466315A3 (en) * | 1990-05-30 | 1992-07-01 | Larrian Gillespie | Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation |
| US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
-
1995
- 1995-06-07 US US08/478,347 patent/US5643892A/en not_active Expired - Fee Related
-
1996
- 1996-05-27 ZA ZA964247A patent/ZA964247B/xx unknown
- 1996-06-03 EP EP96917917A patent/EP0809505B1/en not_active Expired - Lifetime
- 1996-06-03 IL IL12121796A patent/IL121217A/xx not_active IP Right Cessation
- 1996-06-03 HU HU9802431A patent/HUP9802431A3/hu unknown
- 1996-06-03 NZ NZ309991A patent/NZ309991A/en unknown
- 1996-06-03 DE DE0809505T patent/DE809505T1/de active Pending
- 1996-06-03 AU AU60300/96A patent/AU699012B2/en not_active Ceased
- 1996-06-03 WO PCT/US1996/008367 patent/WO1996040158A1/en active IP Right Grant
- 1996-06-03 ES ES96917917T patent/ES2115571T3/es not_active Expired - Lifetime
- 1996-06-03 CA CA002210351A patent/CA2210351C/en not_active Expired - Fee Related
- 1996-08-03 TW TW085109390A patent/TW434018B/zh not_active IP Right Cessation
-
1997
- 1997-07-02 NO NO19973081A patent/NO313686B1/no unknown
- 1997-07-28 BR BR9704114-9A patent/BR9704114A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996040158A1 (en) | 1996-12-19 |
| EP0809505A4 (en) | 1998-07-01 |
| TW434018B (en) | 2001-05-16 |
| AU6030096A (en) | 1996-12-30 |
| NO313686B1 (no) | 2002-11-18 |
| AU699012B2 (en) | 1998-11-19 |
| EP0809505A1 (en) | 1997-12-03 |
| ES2115571T1 (es) | 1998-07-01 |
| ZA964247B (en) | 1996-12-04 |
| HUP9802431A3 (en) | 2001-06-28 |
| ES2115571T3 (es) | 2003-09-01 |
| NO973081D0 (no) | 1997-07-02 |
| BR9704114A (pt) | 2000-06-06 |
| NZ309991A (en) | 2001-03-30 |
| IL121217A0 (en) | 1999-10-28 |
| NO973081L (no) | 1997-08-27 |
| EP0809505B1 (en) | 2003-04-02 |
| CA2210351A1 (en) | 1996-12-19 |
| HUP9802431A2 (hu) | 1999-02-01 |
| DE809505T1 (de) | 1998-05-28 |
| CA2210351C (en) | 2003-09-23 |
| US5643892A (en) | 1997-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1009939A1 (en) | Medicament for treating cardiac inflammatory diseases | |
| IL118418A0 (en) | Pharmaceutical compositions comprising allogenic lymphocytes for cancer therapy | |
| IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
| HUP9601419A3 (en) | Synergetic pharmaceutical compositions for treating parkinson-disease | |
| HUP9900801A3 (en) | Corticosteroid-containing pharmaceutical composition | |
| IL117728A0 (en) | Pharmaceutical compositions for transdermal administration | |
| IL117237A (en) | Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form | |
| IL110421A0 (en) | Pharmaceutical compositions for treating supraventricular tachyarrhythmias | |
| AU2027695A (en) | Pharmaceutical composition for treating stoma-peripheral inflammation diseases | |
| IL121217A (en) | Pharmaceutical compositions containing pentosan polysulfate for treating chronic progressive vascular diseases | |
| ZA968990B (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases. | |
| AU2027495A (en) | Pharmaceutical composition for treating hemorrhoidal diseases | |
| HUP9901303A3 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
| HUP0003256A3 (en) | Use of pentosan polysulfate for preparing medicament useful in treating chronic progressive vascular scarring diseases | |
| HUP9901247A3 (en) | Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency | |
| IL104409A0 (en) | Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy | |
| IT1277117B1 (it) | Composizioni farmaceutiche per il trattamento delle ipercolesterolemie | |
| HK1005497A1 (en) | Use of pentosan polysulfate for the resolution of scars in chronic progressive vascular diseases | |
| IL109414A0 (en) | Pharmaceutical compositions containing sabeluzole for the treatment of chronic neurodegenerative diseases | |
| EP0796105A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES COMPRISING THE B OLIGOMER OF PERTUSSIS TOXIN OR ITS SUB-UNITS | |
| IL115200A0 (en) | Pharmaceutical compositions for the treatment of cancer | |
| AU2575895A (en) | Pharmaceutical composition for treating chronic arterial occlusion | |
| HK1087642A1 (en) | Sterile pharmaceutical composition | |
| SI0858337T1 (sl) | Farmacevtski sestavek za zdravljenje avtoimunskihbolezni | |
| IL134772A0 (en) | Pharmaceutical compositions for piperidinoalkanol compounds in solid unit dosage form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |